Recruiting

Observational Study

Sponsor:

University of Vermont Medical Center

Code:

NCT06280300

Conditions

Brain Metastases, Adult

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

health services intervention

Study Details

Brief summary:

This is a health services intervention study aimed at understanding the impact of intensive multi-disciplinary care compared with standard care on patient-reported symptom outcomes and prognostic awareness in patients with brain metastases.

Conditions

Brain Metastases, Adult

Study ID

NCT06280300

Start date

Nov 16, 2023

Status verified date

Dec, 2025

Completion date

Jul 1, 2027

Anticipated

Primary completion date

Dec 31, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients of all genders must be at least 18 years of age.
  • Patients must have histologically confirmed, newly diagnosed brain metastases from known or suspected solid tumor primary neoplasms.
  • Patients must be able to accurately provide self-report data (e.g. per clinical judgment, cognitive function is intact).
  • Patients must be able to complete questionnaires in English.
  • Patients must have the ability to provide informed consent.

Exclusion Criteria:

  • Patients who are < 18 years of age are not eligible.
  • Patients who are Pregnant are not eligible.

Study Design

Enrollment

40 participants

Anticipated

Allocation

Non randomized

Intervention Model

Parallel Assignment

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

active comparator: Standard of Care

experimental: Multidisciplinary Care

Interventions

health services intervention

Health services intervention

Primary outcome measure

  • Patient reported outcomes [ Time Frame: 6-12 months ]

Central Contacts and Locations

Central contacts

Alissa A Thomas, MD

802-847-8400athoma21@med.uvm.edu

Locations

University of Vermont Medical Center

Recruiting

Burlington, Vermont, United States, 05401

More Information

Sponsor

University of Vermont Medical Center

Last update posted

Jan 29, 2026

Last verified

Dec, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Vermont Medical Center on 2026-01-29.